Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neuroblastoma 19Lung Neoplasms 3Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Prostatic Neoplasms 2Ganglioneuroblastoma 2Carcinoma, Non-Small-Cell Lung 2Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Recurrence 1Penile Neoplasms 1Neuroendocrine Tumors 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm, Residual 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1Keratosis, Actinic 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Gliosarcoma 1Glioma 1

Interventions

Cyclophosphamide 21fludarabine phosphate 18Tacrolimus 14Mycophenolic Acid 14Busulfan 14Antilymphocyte Serum 14Melphalan 12Methotrexate 10Peripheral Blood Stem Cell Transplantation 9Filgrastim 9thymoglobulin 8Whole-Body Irradiation 8Methylprednisolone 8Radiotherapy 7fludarabine 6Granulocyte Colony-Stimulating Factor 6Cytarabine 6Cyclosporine 6Thiotepa 5Stem Cell Transplantation 5Rituximab 5Cord Blood Stem Cell Transplantation 5Etoposide 4Transplantation 3Sirolimus 3Alemtuzumab 3merphos 2blinatumomab 2Prednisone 2Methylprednisolone Hemisuccinate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Myelomonocytic, Juvenile × Isotretinoin × Clear all
NCT00025038 2013-04-11

Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
100 enrolled
Other hematologic neoplasm

Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡